Tune Therapeutics Funding & Investors

Durham, NC

Tune Therapeutics strives to develop paradigm-changing cell and gene therapies that leverage epigenetic programming for the treatment of devastating diseases.

Total Amount Raised: $215,000,000

Tune Therapeutics Funding Rounds

Series B
$175,000,000
Jan 11, 2025
Series B Investors
HEVOLUTION
New Enterprise Associates (NEA)
Regeneron Ventures
Yosemite
Series A
$40,000,000
Dec 1, 2021
Series A Investors
Emerson Collective
New Enterprise Associates (NEA)
Mission BioCapital
Hatteras Venture Partners
Saisei Ventures

Funding info provided by Diffbot.